Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
<p><em>Plasmodium vivax</em> is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease. <e...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2022
|
_version_ | 1797107882124115968 |
---|---|
author | Park, J-H Kim, M-H Sutanto, E Na, S-W Kim, M-J Yeom, JS Nyunt, MH Abbas Elfaki, MM Abdel Hamid, MM Cha, SH Alemu, SG Sriprawat, K Anstey, NM Grigg, MJ Barber, BE William, T Gao, Q Liu, Y Pearson, RD Price, RN Nosten, F Yoon, S-I No, JH Han, E-T Auburn, S Russell, B Han, J |
author_facet | Park, J-H Kim, M-H Sutanto, E Na, S-W Kim, M-J Yeom, JS Nyunt, MH Abbas Elfaki, MM Abdel Hamid, MM Cha, SH Alemu, SG Sriprawat, K Anstey, NM Grigg, MJ Barber, BE William, T Gao, Q Liu, Y Pearson, RD Price, RN Nosten, F Yoon, S-I No, JH Han, E-T Auburn, S Russell, B Han, J |
author_sort | Park, J-H |
collection | OXFORD |
description | <p><em>Plasmodium vivax</em> is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease. <em>P</em>. <em>vivax</em> reticulocyte binding protein 1a (PvRBP1a) is a potential vaccine candidate, which is involved in red cell tropism, a crucial step in the merozoite invasion of host reticulocytes. As part of the initial evaluation of the PvRBP1a vaccine candidate, we investigated its genetic diversity and antigenicity using geographically diverse clinical isolates. We analysed <em>pvrbp1a</em> genetic polymorphisms using 202 vivax clinical isolates from six countries. <em>Pvrbp1a</em> was separated into six regions based on specific domain features, sequence conserved/polymorphic regions, and the reticulocyte binding like (RBL) domains. In the fragmented gene sequence analysis, PvRBP1a region II (RII) and RIII (head and tail structure homolog, 152–625 aa.) showed extensive polymorphism caused by random point mutations. The haplotype network of these polymorphic regions was classified into three clusters that converged to independent populations. Antigenicity screening was performed using recombinant proteins PvRBP1a-N (157–560 aa.) and PvRBP1a-C (606–962 aa.), which contained head and tail structure region and sequence conserved region, respectively. Sensitivity against PvRBP1a-N (46.7%) was higher than PvRBP1a-C (17.8%). PvRBP1a-N was reported as a reticulocyte binding domain and this study identified a linear epitope with moderate antigenicity, thus an attractive domain for merozoite invasion-blocking vaccine development. However, our study highlights that a global PvRBP1a-based vaccine design needs to overcome several difficulties due to three distinct genotypes and low antigenicity levels.</p> |
first_indexed | 2024-03-07T07:20:23Z |
format | Journal article |
id | oxford-uuid:d1146268-a898-49d1-8a7b-a441b67e31d0 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T07:20:23Z |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | dspace |
spelling | oxford-uuid:d1146268-a898-49d1-8a7b-a441b67e31d02022-09-29T10:02:29ZGeographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d1146268-a898-49d1-8a7b-a441b67e31d0EnglishSymplectic ElementsPublic Library of Science2022Park, J-HKim, M-HSutanto, ENa, S-WKim, M-JYeom, JSNyunt, MHAbbas Elfaki, MMAbdel Hamid, MMCha, SHAlemu, SGSriprawat, KAnstey, NMGrigg, MJBarber, BEWilliam, TGao, QLiu, YPearson, RDPrice, RNNosten, FYoon, S-INo, JHHan, E-TAuburn, SRussell, BHan, J<p><em>Plasmodium vivax</em> is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease. <em>P</em>. <em>vivax</em> reticulocyte binding protein 1a (PvRBP1a) is a potential vaccine candidate, which is involved in red cell tropism, a crucial step in the merozoite invasion of host reticulocytes. As part of the initial evaluation of the PvRBP1a vaccine candidate, we investigated its genetic diversity and antigenicity using geographically diverse clinical isolates. We analysed <em>pvrbp1a</em> genetic polymorphisms using 202 vivax clinical isolates from six countries. <em>Pvrbp1a</em> was separated into six regions based on specific domain features, sequence conserved/polymorphic regions, and the reticulocyte binding like (RBL) domains. In the fragmented gene sequence analysis, PvRBP1a region II (RII) and RIII (head and tail structure homolog, 152–625 aa.) showed extensive polymorphism caused by random point mutations. The haplotype network of these polymorphic regions was classified into three clusters that converged to independent populations. Antigenicity screening was performed using recombinant proteins PvRBP1a-N (157–560 aa.) and PvRBP1a-C (606–962 aa.), which contained head and tail structure region and sequence conserved region, respectively. Sensitivity against PvRBP1a-N (46.7%) was higher than PvRBP1a-C (17.8%). PvRBP1a-N was reported as a reticulocyte binding domain and this study identified a linear epitope with moderate antigenicity, thus an attractive domain for merozoite invasion-blocking vaccine development. However, our study highlights that a global PvRBP1a-based vaccine design needs to overcome several difficulties due to three distinct genotypes and low antigenicity levels.</p> |
spellingShingle | Park, J-H Kim, M-H Sutanto, E Na, S-W Kim, M-J Yeom, JS Nyunt, MH Abbas Elfaki, MM Abdel Hamid, MM Cha, SH Alemu, SG Sriprawat, K Anstey, NM Grigg, MJ Barber, BE William, T Gao, Q Liu, Y Pearson, RD Price, RN Nosten, F Yoon, S-I No, JH Han, E-T Auburn, S Russell, B Han, J Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title | Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title_full | Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title_fullStr | Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title_full_unstemmed | Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title_short | Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
title_sort | geographical distribution and genetic diversity of plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity |
work_keys_str_mv | AT parkjh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT kimmh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT sutantoe geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT nasw geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT kimmj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT yeomjs geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT nyuntmh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT abbaselfakimm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT abdelhamidmm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT chash geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT alemusg geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT sriprawatk geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT ansteynm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT griggmj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT barberbe geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT williamt geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT gaoq geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT liuy geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT pearsonrd geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT pricern geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT nostenf geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT yoonsi geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT nojh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT hanet geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT auburns geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT russellb geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity AT hanj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity |